IGM Biosciences, Inc. Comprehensive Income
IGM Biosciences, Inc. reported Comprehensive Income of $97.51 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-07-31
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was $97.51M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$52.97M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$36.91M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$60.81M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$195.79M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$245.56M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$221.74M.
- IGM Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$165.26M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-06-30 | $97.51M 10-Q · filed 2025-07-31 | $44.54M 10-Q · filed 2025-07-31 | $7.63M derived: sum of 3 quarters · filed 2025-07-31 | -$53.18M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | -$52.97M 10-Q · filed 2025-05-13 | -$89.88M derived: sum of 2 quarters · filed 2025-05-13 | -$150.69M derived: sum of 3 quarters · filed 2025-05-13 | -$198.66M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | -$36.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$97.72M derived: sum of 2 quarters · filed 2025-03-06 | -$145.69M derived: sum of 3 quarters · filed 2025-07-31 | -$195.79M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$60.81M 10-Q · filed 2024-11-08 | -$108.78M derived: sum of 2 quarters · filed 2025-07-31 | -$158.88M 10-Q · filed 2024-11-08 | -$219.15M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | -$47.97M 10-Q · filed 2025-07-31 | -$98.06M 10-Q · filed 2025-07-31 | -$158.33M derived: sum of 3 quarters · filed 2025-07-31 | -$220.15M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$50.09M 10-Q · filed 2025-05-13 | -$110.36M derived: sum of 2 quarters · filed 2025-05-13 | -$172.18M derived: sum of 3 quarters · filed 2025-05-13 | -$236.70M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$60.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$122.08M derived: sum of 2 quarters · filed 2025-03-06 | -$186.61M derived: sum of 3 quarters · filed 2025-03-06 | -$245.56M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$61.81M 10-Q · filed 2024-11-08 | -$126.34M derived: sum of 2 quarters · filed 2024-11-08 | -$185.30M 10-Q · filed 2024-11-08 | -$237.80M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$64.53M 10-Q · filed 2024-08-14 | -$123.48M 10-Q · filed 2024-08-14 | -$175.99M derived: sum of 3 quarters · filed 2025-03-06 | -$234.34M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | -$58.95M 10-Q · filed 2024-05-08 | -$111.46M derived: sum of 2 quarters · filed 2025-03-06 | -$169.81M derived: sum of 3 quarters · filed 2025-03-06 | -$228.67M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | -$52.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$110.85M derived: sum of 2 quarters · filed 2025-03-06 | -$169.72M derived: sum of 3 quarters · filed 2025-03-06 | -$221.74M 10-K · filed 2025-03-06 |
| 2022-09-30 | -$58.35M 10-Q · filed 2023-11-13 | -$117.21M derived: sum of 2 quarters · filed 2023-11-13 | -$169.24M 10-Q · filed 2023-11-13 | -$219.94M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | -$58.86M 10-Q · filed 2023-08-03 | -$110.89M 10-Q · filed 2023-08-03 | -$161.59M derived: sum of 3 quarters · filed 2024-03-07 | -$205.75M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$52.02M 10-Q · filed 2023-05-12 | -$102.73M derived: sum of 2 quarters · filed 2024-03-07 | -$146.89M derived: sum of 3 quarters · filed 2024-03-07 | -$185.62M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$50.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$94.87M derived: sum of 2 quarters · filed 2024-03-07 | -$133.60M derived: sum of 3 quarters · filed 2024-03-07 | -$165.26M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$44.16M 10-Q · filed 2022-11-03 | -$82.89M derived: sum of 2 quarters · filed 2022-11-03 | -$114.55M 10-Q · filed 2022-11-03 | -$139.26M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$38.73M 10-Q · filed 2022-08-08 | -$70.39M 10-Q · filed 2022-08-08 | -$95.09M derived: sum of 3 quarters · filed 2023-03-30 | -$115.55M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | -$31.66M 10-Q · filed 2022-05-09 | -$56.37M derived: sum of 2 quarters · filed 2023-03-30 | -$76.82M derived: sum of 3 quarters · filed 2023-03-30 | -$95.57M derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | -$24.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$45.16M derived: sum of 2 quarters · filed 2023-03-30 | -$63.91M derived: sum of 3 quarters · filed 2023-03-30 | -$81.37M 10-K · filed 2023-03-30 |
| 2020-09-30 | -$20.45M 10-Q · filed 2021-11-04 | -$39.20M derived: sum of 2 quarters · filed 2021-11-04 | -$56.66M 10-Q · filed 2021-11-04 | -$71.46M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-06-30 | -$18.75M 10-Q · filed 2021-08-09 | -$36.21M 10-Q · filed 2021-08-09 | -$51.01M derived: sum of 3 quarters · filed 2022-03-29 | -$61.15M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-03-31 | -$17.46M 10-Q · filed 2021-05-06 | -$32.26M derived: sum of 2 quarters · filed 2022-03-29 | -$42.41M derived: sum of 3 quarters · filed 2022-03-29 | -$53.08M derived: sum of 4 quarters · filed 2022-03-29 |
| 2019-12-31 | -$14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$24.94M derived: sum of 2 quarters · filed 2022-03-29 | -$35.62M derived: sum of 3 quarters · filed 2022-03-29 | -$43.09M 10-K · filed 2022-03-29 |
| 2019-09-30 | -$10.14M 10-Q · filed 2020-11-05 | -$20.82M derived: sum of 2 quarters · filed 2020-11-05 | -$28.29M 10-Q · filed 2020-11-05 | -$37.34M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | -$10.68M 10-Q · filed 2020-08-06 | -$18.15M 10-Q · filed 2020-08-06 | -$27.20M derived: sum of 3 quarters · filed 2021-03-30 | -$33.72M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | -$7.47M 10-Q · filed 2020-05-07 | -$16.52M derived: sum of 2 quarters · filed 2021-03-30 | -$23.04M derived: sum of 3 quarters · filed 2021-03-30 | |
| 2018-12-31 | -$9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$15.57M derived: sum of 2 quarters · filed 2021-03-30 | -$22.71M 10-K · filed 2021-03-30 | |
| 2018-09-30 | -$6.52M 10-Q · filed 2019-11-07 | -$13.66M 10-Q · filed 2019-11-07 | ||
| 2017-12-31 | -$11.05M 10-K · filed 2020-03-26 |